Abstract
Lung toxicity related to interferon (IFN) alpha typically takes a form of interstitial pneumonitis, granulomatous inflammation, or organizing pneumonia. We report a case of a 52-year-old woman, who developed pneumonitis with exudative, lymphocytic-predominant pleural effusion following treatment with pegylated IFN alpha and ribavirin for hepatitis C. Her symptoms and lung findings resolved over 3 months of observation without corticosteroid therapy.
Copyright 2009 Society of Hospital Medicine.
MeSH terms
-
Female
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / adverse effects*
-
Interferon-alpha / therapeutic use
-
Middle Aged
-
Pleural Effusion / chemically induced*
-
Polyethylene Glycols / adverse effects*
-
Polyethylene Glycols / therapeutic use
-
Recombinant Proteins
-
Ribavirin / adverse effects*
-
Ribavirin / therapeutic use
-
Tomography, X-Ray Computed
Substances
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
Ribavirin
-
peginterferon alfa-2a